|
Q1 2022
Filed on May 16, 2022
|
1,824,542
|
$7.78 - $15.31
$14.2M - $27.9M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
14,541
|
$247.59 - $304.47
$3.6M - $4.43M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
1,694,017
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
449,951
|
$7.7 - $37.13
$3.46M - $16.7M
|
|
|
Q2 2021
Filed on Aug 16, 2021
|
275,034
|
$7.84 - $12.6
$2.16M - $3.47M
|
|
|
Q1 2021
Filed on May 17, 2021
|
1,662,646
|
$16.95 - $42.8
$28.2M - $71.2M
|
|
|
Q1 2021
Filed on May 17, 2021
|
510,142
|
N/A
|
|
|
Q1 2021
Filed on May 17, 2021
|
1,719,576
|
$14.69 - $42.57
$25.3M - $73.2M
|
|
Catabasis Pharmaceuticals In
|
Q4 2020
Filed on Feb 16, 2021
|
285,765
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
312,068
|
$7.36 - $9.87
$2.3M - $3.08M
|
|
Reshape Life Sciences Inc
|
Q1 2019
Filed on May 15, 2019
|
1,072
|
N/A
|
|
Catabasis Pharmaceuticals In
|
Q1 2019
Filed on May 15, 2019
|
285,765
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
1,868,961
|
N/A
|
|
Reshape Life Sciences Inc
|
Q2 2018
Filed on Aug 06, 2018
|
2,250,958
|
N/A
|
|
|
Q1 2018
Filed on May 15, 2018
|
2,956,456
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,275,779
|
N/A
|
|